June 2013. Volume 9. Number 2

Preliminary results of the 13-valent pneumococcal conjugate vaccine

 
 
 
 
 
 
 
 
 
 
Rating: 0 (0 Votes)
Newsletter Free Subscription
Regularly recieve most recent articles by e-mail
Subscribe
Print
Add to library
Discuss this article

AVC | Critically appraised articles

Kaplan SL, Barson WJ, Lin PL, Romero JR, Bradley JS, Tan TQ, et al. Early Trends for Invasive Pneumococcal Infections in Children After the Introduction of the 13-valent Pneumococcal Conjugate Vaccine. Pediatr Infect Dis J. 2013 Mar; 32:203-7.
Reviewers: Río-García MD1, Molina Arias M2.
1Servicio de Cuidados Intensivos Pediátricos del Hospital Infantil Universitario La Paz. Madrid. España.
2Servicio de Gastroenterología y Nutrición. Hospital Infantil Universitario La Paz. Madrid. España.
Correspondence: Miguel David Río-García. Email: delrio.md@gmail.com
Reception date: 24/04/2013
Acceptance date: 09/05/2013
Publication date: 16/05/2013

Abstract

Authors' conclusions: routine vaccination with 13-valent pneumococcal vaccine decreases the incidence of invasive pneumococcal disease.

Reviewers' commentary: vaccination with the PCV13 appears more effective than PCV7, although it would be interesting to study the cost-effectiveness of the vaccine and the possible increase of other serotypes causing infection.

How to cite this article

Río-García MD, Molina Arias M. Resultados preliminares de la vacuna frente a 13 serotipos de neumococo. Evid Pediatr. 2013;9:28.

AVC | Critically appraised articles

Kaplan SL, Barson WJ, Lin PL, Romero JR, Bradley JS, Tan TQ, et al. Early Trends for Invasive Pneumococcal Infections in Children After the Introduction of the 13-valent Pneumococcal Conjugate Vaccine. Pediatr Infect Dis J. 2013 Mar; 32:203-7.
Reviewers: Río-García MD1, Molina Arias M2.
1Servicio de Cuidados Intensivos Pediátricos del Hospital Infantil Universitario La Paz. Madrid. España.
2Servicio de Gastroenterología y Nutrición. Hospital Infantil Universitario La Paz. Madrid. España.
Correspondence: Miguel David Río-García. Email: delrio.md@gmail.com
Reception date: 24/04/2013
Acceptance date: 09/05/2013
Publication date: 16/05/2013

How to cite this article

Río-García MD, Molina Arias M. Resultados preliminares de la vacuna frente a 13 serotipos de neumococo. Evid Pediatr. 2013;9:28.

References

  1. Ochoa Sangrador C, Andrés de Llano JM. ¿Es coste-efectiva la vacunación de rescate frente a 13 serotipos de neumococo? Evid Pediatr. 2012;8:10.
  2. Miller E, Andrews NJ, Waight PA, Slack MP, George RC. Effectiveness of the new serotypes in the 13-valent pneumococcal conjugate vaccine. Vaccine. 2011;29:9127-31.
  3. Bryant KA, Block SL, Baker SA, Gruber WC, Scott DA; PCV13 Infant Study Group. Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine. Pediatrics. 2010;125:866-75.
  4. Rozenbaum MH, van Hoek AJ, Fleming D, Trotter CL, Miller E, Edmunds WJ. Vaccination of risk groups in England using the 13 valent pneumococcal conjugate vaccine: economic analysis. BMJ. 2012;345:e6879.
16/05/2013

Linked Comment